May 13, 2020 / 9:03 PM / 13 days ago

BRIEF-BridgeBio Pharma Quarterly Loss Per Share $0.78

May 13 (Reuters) - BridgeBio Pharma Inc:

* BRIDGEBIO PHARMA, INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATE

* BRIDGEBIO PHARMA INC QUARTERLY LOSS PER SHARE $0.78

* BRIDGEBIO PHARMA INC - CERTAIN CLINICAL TRIALS THAT WERE IN PROCESS OF ENROLLING HAVE SLOWED AS A RESULT OF COVID-19 OUTBREAK

* BRIDGEBIO PHARMA - ESTIMATE CERTAIN MILESTONES RELATED TO CLINICAL TRIALS THAT WERE ANTICIPATED IN 2020 ARE NOW MORE LIKELY TO COME IN 2021

* BRIDGEBIO PHARMA - EXPECTS CURRENT CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES TO CARRY CO THROUGH MILESTONES STRETCHING INTO 2022

* BRIDGEBIO PHARMA INC - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES, EXCLUDING RESTRICTED CASH, TOTALED $928.4 MILLION AS OF MARCH 31 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below